Month: April 2024

DURHAM, N.C., April 18, 2024 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest townhome community, Rollingdale by Toll Brothers, is coming soon to Durham, North Carolina. The Toll Brothers Sales Center and model home are currently under construction and the community will open for sale in late summer 2024. summer 2024. Located just five minutes from The Streets at Southpoint shopping mall, Rollingdale by Toll Brothers will be an intimate community of 33 modern townhomes in a prime location. Buyers will have a choice of three-story townhomes with all-new architectural designs, starting from the mid-$400,000s. This collection of homes will offer 4 bedrooms, 3.5 bathrooms, open-concept living levels, versatile flex spaces, and spacious 2-car garages. “Toll Brothers...

TORONTO, April 18, 2024 (GLOBE NEWSWIRE) — Class 1 Nickel and Technologies Ltd. (CSE: NICO | OTCQB: NICLF) (“Class 1 Nickel” or the “Company”) is pleased to announce that Caracle Creek Chile SpA (“Caracle”) and their strategic partner Atticus Geoscience Consulting Ltd. (“Atticus”) (together the “Consultants”) have completed the first stage of a comprehensive independent review of both the Alexo-Dundonald and Somanike nickel projects. Work is near-complete on the delivery of an updated Mineral Resource Estimate (“MRE”) for the Alexo South Nickel Deposit, one of 4 nickel deposits on the Alexo-Dundonald Project (the “Project”), located about 45 km northeast of the City of Timmins, Ontario and covering approximately 1,895 hectares (18.95 km2). Updates to the other 3 nickel mineral resources contained within...

COSTA MESA, CA., April 18, 2024 (GLOBE NEWSWIRE) — Clean Energy Technologies, Inc. (Nasdaq: CETY) (“CETY” or the “Company”), a clean energy manufacturing and services company, offering eco-friendly green energy solutions, clean energy fuels, and alternative electric power for small and mid-sized projects in North America, Europe, and Asia announces that it has signed an Memorandum of Understanding with Asia Management Energy Capital Partners Pte. Ltd. (AMEC), an international private equity fund specializing in areas of alternative and renewable energy and climate technologies. AMEC agrees, subject to final approval, to facilitate financing and investment into CETY as its growth capital to develop the waste to energy project in Vermont under Vermont Renewable Gas (VRG), as well as provide growth capital to expand into California...

ATHENS, Greece, April 18, 2024 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that, through a separate wholly-owned subsidiary, it has entered into a time charter contract with Bohai Shipping (HEBEI) Co., Ltd, for one of its Capesize dry bulk vessels, the m/v P. S. Palios. The gross charter rate is US$27,150 per day, minus a 5% commission paid to third parties, for a period until minimum November 1, 2025 up to maximum December 31, 2025. The charter is expected to commence on May 12, 2024. The “P. S. Palios” is a 179,134 dwt Capesize dry bulk vessel built in 2013. The employment of “P. S. Palios” is anticipated to generate approximately US$14.39 million of gross revenue for the minimum scheduled...

FREMONT, CA, April 18, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — ABVC BioPharma, Inc. (NASDAQ: ABVC) (“Company”), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and Oncology/Hematology, announced today that the Company’s subsidiary AiBtl BioPharma Inc. acquired TT Life Company, an established player in the precision medicine industry. The acquisition includes Malaysian Import Trading Company, Direct Sales Company, and Taiwanese Direct Sales Company, which are estimated to be approximately equivalent to $8.33M. AiBtl purchased 100% shares of TT Life by swapping its 1.66M shares at $5 per share. This strategic move positions AiBtl to expand its portfolio further and accelerate innovation in the rapidly growing precision medicine market...